Regulus Therapeutics Inc (RGLS)

Dec 21, 2024

Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives $10.80 Average Target Price from Analysts - Defense World

Dec 21, 2024

Dec 19, 2024

Institutional investors may overlook Regulus Therapeutics Inc.'s (NASDAQ:RGLS) recent US$12m market cap drop as long-term gains remain positive - Simply Wall St

Dec 19, 2024

Dec 19, 2024

Fmr LLC Has $515,000 Stake in Regulus Therapeutics Inc. (NASDAQ:RGLS) - MarketBeat

Dec 19, 2024

Dec 18, 2024

Regulus To Provide First Quarter 2017 Financial Results On May 4, 2017 - BioSpace

Dec 18, 2024

Dec 18, 2024

Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives $10.80 Average Price Target from Brokerages - MarketBeat

Dec 18, 2024

Dec 17, 2024

The Manufacturers Life Insurance Company Purchases New Holdings in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World

Dec 17, 2024

Dec 16, 2024

Regulus Therapeutics Announces First Patient Dosed in Third Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) - StockTitan

Dec 16, 2024

Dec 12, 2024

Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences - Longview News-Journal

Dec 12, 2024

Dec 11, 2024

Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences - The Eastern Progress Online

Dec 11, 2024

Dec 11, 2024

Point72 Asset Management L.P. Takes $1.40 Million Position in Regulus Therapeutics Inc. (NASDAQ:RGLS) - MarketBeat

Dec 11, 2024

Dec 08, 2024

With 64% institutional ownership, Regulus Therapeutics Inc. (NASDAQ:RGLS) is a favorite amongst the big guns - Yahoo Finance

Dec 08, 2024

Dec 05, 2024

RA Capital Management L.P. Sells 5,483,166 Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) - MarketBeat

Dec 05, 2024

Dec 01, 2024

NEA Management Company LLC Buys Shares of 6,467,802 Regulus Therapeutics Inc. (NASDAQ:RGLS) - MarketBeat

Dec 01, 2024

Nov 29, 2024

Victory Capital Management Inc. Has $626,000 Holdings in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World

Nov 29, 2024

Nov 26, 2024

Regulus Therapeutics Announces Participation at Upcoming Healthc - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

Regulus Therapeutics to Present at Evercore and Piper Sandler Healthcare Conferences - StockTitan

Nov 26, 2024

Nov 23, 2024

Brokerages Set Regulus Therapeutics Inc. (NASDAQ:RGLS) Price Target at $10.80 - MarketBeat

Nov 23, 2024

Nov 21, 2024

Regulus Therapeutics Reports Q3 2024 Financial Results - TipRanks

Nov 21, 2024

Nov 21, 2024

Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates - GuruFocus.com

Nov 21, 2024

Nov 16, 2024

Annovis Bio (NYSE:ANVS) versus Regulus Therapeutics (NASDAQ:RGLS) Head-To-Head Contrast - Defense World

Nov 16, 2024

Nov 15, 2024

RA Capital Management's Strategic Reduction in Regulus Therapeutics Holdings - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

Biotechnology Value Fund L.P. Increases Stake in Regulus Therape - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

What is HC Wainwright’s Estimate for RGLS FY2024 Earnings? - Defense World

Nov 15, 2024

Nov 14, 2024

FY2024 Earnings Forecast for RGLS Issued By HC Wainwright - MarketBeat

Nov 14, 2024

Nov 14, 2024

Creative Planning Makes New Investment in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World

Nov 14, 2024

Nov 11, 2024

Regulus Therapeutics (NASDAQ:RGLS) Receives Buy Rating from HC Wainwright - MarketBeat

Nov 11, 2024

Nov 07, 2024

Regulus: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 07, 2024

Nov 06, 2024

Regulus Therapeutics (RGLS) Stock Price, News & Analysis - MarketBeat

Nov 06, 2024

Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Regulus Therapeuti - GuruFocus.com

Nov 05, 2024

Oct 30, 2024

HC Wainwright Reiterates Buy Rating for Regulus Therapeutics (NASDAQ:RGLS) - MarketBeat

Oct 30, 2024

Oct 29, 2024

Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives $10.80 Average PT from Analysts - MarketBeat

Oct 29, 2024

Oct 29, 2024

These 2 ‘Strong Buy’ Penny Stocks Could Rally Over 500%, Say Analysts - Yahoo Finance

Oct 29, 2024

Oct 24, 2024

Regulus Therapeutics secures exclusive license for kidney disease treatment - Investing.com India

Oct 24, 2024

Oct 24, 2024

Regulus Therapeutics secures exclusive license for kidney disease treatment By Investing.com - Investing.com South Africa

Oct 24, 2024

Oct 24, 2024

Regulus Therapeutics Inc. Enters into Patent & Technology License Agreement with the Board of Regents of the University of Texas System - Marketscreener.com

Oct 24, 2024

Oct 19, 2024

Financial Survey: Regulus Therapeutics (NASDAQ:RGLS) & Ironwood Pharmaceuticals (NASDAQ:IRWD) - Defense World

Oct 19, 2024

Oct 13, 2024

Renaissance Technologies LLC Has $211,000 Position in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World

Oct 13, 2024

Oct 08, 2024

HC Wainwright Reaffirms "Buy" Rating for Regulus Therapeutics (NASDAQ:RGLS) - MarketBeat

Oct 08, 2024

Oct 08, 2024

RGLSRegulus Therapeutics Inc. Latest Stock News & Market Updates - StockTitan

Oct 08, 2024

Oct 08, 2024

Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) - PR Newswire

Oct 08, 2024

Oct 04, 2024

Analysts Set Regulus Therapeutics Inc. (NASDAQ:RGLS) PT at $10.80 - MarketBeat

Oct 04, 2024

Oct 03, 2024

Company’s Banking Stock: Dissecting a -7.22% Quarterly Revenue Decline Amid Growth - The InvestChronicle

Oct 03, 2024

Oct 03, 2024

Regulus Therapeutics Inc [RGLS] stock for 7,280 USD was acquired by Collier Kathryn J - Knox Daily

Oct 03, 2024

Sep 28, 2024

Regulus Therapeutics Inc. (NASDAQ:RGLS) Shares Sold by CVI Holdings LLC - MarketBeat

Sep 28, 2024

Sep 28, 2024

Companies Like Regulus Therapeutics (NASDAQ:RGLS) Are In A Position To Invest In Growth - Simply Wall St

Sep 28, 2024

Sep 24, 2024

ProMIS Neurosciences (NASDAQ:PMN) versus Regulus Therapeutics (NASDAQ:RGLS) Critical Contrast - Defense World

Sep 24, 2024

Sep 23, 2024

Investing in Regulus Therapeutics Inc (RGLS) Is Getting More Attractive - Knox Daily

Sep 23, 2024

Sep 23, 2024

Victory Capital Management Inc. Has $645,000 Position in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World

Sep 23, 2024

Sep 19, 2024

Regulus Therapeutics (NASDAQ:RGLS) Stock Rating Upgraded by StockNews.com - Defense World

Sep 19, 2024

Sep 17, 2024

Regulus Therapeutics (NASDAQ:RGLS) Upgraded to "Sell" by StockNews.com - MarketBeat

Sep 17, 2024

Sep 11, 2024

Oppenheimer’s latest rating for RGLS stock - Knox Daily

Sep 11, 2024